330
Views
0
CrossRef citations to date
0
Altmetric
Corrigenda

Corrigendum

This article refers to:
Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells

Hu H, Li Y, Gu G, et al. Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Leuk. Lymphoma. 2010;51:694–701. http://dx.doi.org/10.3109/10428191003596835

The authors of the above article report that in the published version of Figure 5(c), the Blank image is a duplicate of the SCR image. The correct figure is reproduced below.

Figure 5. ASO-miR-21 up-regulation of PDCD4 mRNA and protein levels. K562 cells were transfected with 0.4 μM ASO-miR-21 and harvested 48 h after transfection. Total RNA was isolated and analyzed for PDCD4 mRNA. PDCD4 protein level was determined by fluorescence immunohistochemistry and Western blot. (A) PDCD4 mRNA relative expression level by SYBR-Green real-time PCR. *p < 0.01, as compared with controls. (B) PDCD4 protein expression level by Western blot. *p < 0.01, as compared with controls. (C) PDCD4 protein expression level by confocal microscopy.

Figure 5. ASO-miR-21 up-regulation of PDCD4 mRNA and protein levels. K562 cells were transfected with 0.4 μM ASO-miR-21 and harvested 48 h after transfection. Total RNA was isolated and analyzed for PDCD4 mRNA. PDCD4 protein level was determined by fluorescence immunohistochemistry and Western blot. (A) PDCD4 mRNA relative expression level by SYBR-Green real-time PCR. *p < 0.01, as compared with controls. (B) PDCD4 protein expression level by Western blot. *p < 0.01, as compared with controls. (C) PDCD4 protein expression level by confocal microscopy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.